Analyze the correlation between Porui's M&A and its share price and shareholding.

Taiwan's biotech and medical industry is still in the dilemma of being small and beautiful (small scale of operation), as well as insufficient international market share and volume of foreign sales (not a large share of export earnings), and the M&A strategy to play the International Cup seems to be one of the ways to break the ice, and the issuance of bonds to raise funds for the convertible bonds (CBs) can provide relatively low-cost, highly efficient fundraising, and equity is not easy to be diluted in the fundraising tool.